Richard Mackay

Summary

Country: New Zealand

Publications

  1. ncbi Sweat testing for cystic fibrosis: A review of New Zealand laboratories
    Richard Mackay
    Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand
    J Paediatr Child Health 42:160-4. 2006
  2. ncbi Detection of treatable neonatal liver disease by expanded newborn screening
    R J MacKay
    Department of Genetic Medicine, Women s and Children s Hospital, Adelaide, South Australia, Australia
    J Inherit Metab Dis 31:S271-3. 2008
  3. ncbi Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?
    R J MacKay
    Biochemistry Unit, Canterbury Health Laboratories, PO Box 151, Christchurch 8011, New Zealand
    Ann Clin Biochem 45:535-8. 2008
  4. ncbi High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain
    Sally J Aldous
    Cardiology Department, Christchurch Hospital, Riccarton Road, Christchurch, New Zealand
    Ann Clin Biochem 48:249-55. 2011
  5. ncbi Spectrum of MECP2 mutations in New Zealand Rett syndrome patients
    Anthony M Raizis
    Department of Molecular Pathology, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand
    N Z Med J 122:21-8. 2009
  6. ncbi Has the prevalence and severity of symptoms of asthma changed among children in New Zealand? ISAAC Phase Three
    M Innes Asher
    Department of Paediatrics Child and Youth Health, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand
    N Z Med J 121:52-63. 2008

Collaborators

Detail Information

Publications6

  1. ncbi Sweat testing for cystic fibrosis: A review of New Zealand laboratories
    Richard Mackay
    Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand
    J Paediatr Child Health 42:160-4. 2006
    ..Evolving diagnostic criteria for cystic fibrosis, broadening of the populations being tested and the need to interpret intermediate sweat test results have imposed a much greater need to standardize the collection and analysis of sweat...
  2. ncbi Detection of treatable neonatal liver disease by expanded newborn screening
    R J MacKay
    Department of Genetic Medicine, Women s and Children s Hospital, Adelaide, South Australia, Australia
    J Inherit Metab Dis 31:S271-3. 2008
    ..Neonatal haemochromatosis is an example of one such disease that is potentially treatable...
  3. ncbi Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?
    R J MacKay
    Biochemistry Unit, Canterbury Health Laboratories, PO Box 151, Christchurch 8011, New Zealand
    Ann Clin Biochem 45:535-8. 2008
    ..This has important implications for reporting...
  4. ncbi High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain
    Sally J Aldous
    Cardiology Department, Christchurch Hospital, Riccarton Road, Christchurch, New Zealand
    Ann Clin Biochem 48:249-55. 2011
    ..The aim of this study was to compare prognostic utility of high-sensitivity troponin with contemporary troponin assays in such patients...
  5. ncbi Spectrum of MECP2 mutations in New Zealand Rett syndrome patients
    Anthony M Raizis
    Department of Molecular Pathology, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand
    N Z Med J 122:21-8. 2009
    ..Approximately 65-85% of patients with classical Rett syndrome have identifiable MECP2 mutations. In comparison, up to 57% of patients with atypical Rett have mutations in the MECP2 gene...
  6. ncbi Has the prevalence and severity of symptoms of asthma changed among children in New Zealand? ISAAC Phase Three
    M Innes Asher
    Department of Paediatrics Child and Youth Health, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand
    N Z Med J 121:52-63. 2008
    ..To investigate time trends in prevalence of symptoms of asthma by repeating, during 2001-3 (Phase Three), the International Study of Asthma and Allergies in Childhood (ISAAC) Phase One study that was conducted in New Zealand in 1992-3...